• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性骨质疏松症中的甲状旁腺功能

Parathyroid function in primary osteoporosis.

作者信息

Riggs B L, Arnaud C D, Jowsey J, Goldsmith R S, Kelly P J

出版信息

J Clin Invest. 1973 Jan;52(1):181-4. doi: 10.1172/JCI107162.

DOI:10.1172/JCI107162
PMID:4734167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC302240/
Abstract

Two major species of serum immunoreactive parathyroid hormone (iPTH) were measured in 47 untreated patients with primary osteoporosis by using two highly specific radioimmunoassays. Mean iPTH was normal with one antiserum but was lower than normal (P < 0.001) with the other, iPTH values did not correlate with biochemical parameters or with the proportion of bone-resorbing surfaces in iliac crest bone biopsy specimens. These data suggest that the increased bone resorption is not due to increased parathyroid function in most osteoporotic patients. However, seven of our patients (15%) appear to represent a separate population because they had increased values with one or the other of the antisera.

摘要

通过两种高度特异性放射免疫分析法,对47例未经治疗的原发性骨质疏松症患者的血清免疫反应性甲状旁腺激素(iPTH)的两种主要类型进行了测定。使用一种抗血清时,iPTH平均值正常,但使用另一种抗血清时低于正常水平(P<0.001),iPTH值与生化参数或髂嵴骨活检标本中骨吸收表面的比例无关。这些数据表明,在大多数骨质疏松症患者中,骨吸收增加并非由于甲状旁腺功能增强。然而,我们的7例患者(15%)似乎代表了一个不同的群体,因为他们使用其中一种抗血清时数值升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c38/302240/8d82387cba04/jcinvest00177-0190-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c38/302240/8d82387cba04/jcinvest00177-0190-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c38/302240/8d82387cba04/jcinvest00177-0190-a.jpg

相似文献

1
Parathyroid function in primary osteoporosis.原发性骨质疏松症中的甲状旁腺功能
J Clin Invest. 1973 Jan;52(1):181-4. doi: 10.1172/JCI107162.
2
[Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)].[高骨重塑与甲状旁腺功能状态下的骨质疏松症。组织生物学对比(作者译)]
Sem Hop. 1981;57(5-6):266-73.
3
[Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)].[高骨重建与甲状旁腺功能状态下的骨质疏松症。组织生物学对比研究(作者译)]
Pathol Biol (Paris). 1980 Sep;28(7):417-24.
4
The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women.年龄对正常及骨质疏松女性血清免疫反应性甲状旁腺激素的影响。
J Lab Clin Med. 1980 Mar;95(3):373-85.
5
Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.原发性甲状旁腺功能亢进症及肾衰竭所致甲状旁腺功能亢进症中免疫反应性甲状旁腺激素分子形式的特征分析
Scand J Clin Lab Invest. 1983 Nov;43(7):553-64.
6
Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.前列腺来源骨转移患者的甲状旁腺功能和维生素D状态
Miner Electrolyte Metab. 1985;11(2):117-22.
7
Parathyroid hormone: radioimmunoassay and clinical interpretation.甲状旁腺激素:放射免疫测定及临床解读。
Ann Clin Lab Sci. 1975 Sep-Oct;5(5):383-98.
8
Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism.人甲状旁腺激素序列特异性放射免疫测定法的研制及其在甲状旁腺功能亢进诊断中的应用。
Scand J Clin Lab Invest. 1979 Sep;39(5):469-78. doi: 10.3109/00365517909106133.
9
PTH bioactivity in osteoporosis.骨质疏松症中的甲状旁腺激素生物活性。
Bone Miner. 1987 Oct;3(1):75-83.
10
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.慢性血液透析期间甲状旁腺功能亢进和骨病的病因。3. 甲状旁腺抑制性评估。
J Clin Invest. 1973 Jan;52(1):173-80. doi: 10.1172/JCI107161.

引用本文的文献

1
Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency.I型骨质疏松症是由骨骼对雌激素缺乏的反应性增强所致的证据。
Osteoporos Int. 2003 Sep;14(9):728-33. doi: 10.1007/s00198-003-1437-9. Epub 2003 Jul 18.
2
Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.体重相同的绝经后女性中,患有和未患骨质疏松症者的激素变化情况,包括与绝经时间的关系。
Clin Rheumatol. 1984 Sep;3(3):337-43. doi: 10.1007/BF02032340.
3
Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.

本文引用的文献

1
QUANTITATIVE MICRORADIOGRAPHIC STUDIES OF NORMAL AND OSTEOPOROTIC BONE.正常与骨质疏松性骨的定量显微放射学研究
J Bone Joint Surg Am. 1965 Jun;47:785-806.
2
MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD.体内骨矿物质的测量:一种改进方法。
Science. 1963 Oct 11;142(3589):230-2. doi: 10.1126/science.142.3589.230.
3
Bone resorption rates in rib in physiological, senile, and postmenopausal osteoporoses.生理状态、老年及绝经后骨质疏松症中肋骨的骨吸收速率
绝经后骨质疏松症患者血清骨钙素(BGP)及其他骨矿物质代谢标志物
Calcif Tissue Int. 1986 Oct;39(4):230-3. doi: 10.1007/BF02555209.
4
Desensitization to parathyroid hormone in renal cells from aged rats is associated with alterations in G-protein activity.老年大鼠肾细胞对甲状旁腺激素的脱敏作用与G蛋白活性改变有关。
J Clin Invest. 1989 Jan;83(1):268-77. doi: 10.1172/JCI113869.
5
Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type I osteoporosis: evidence that skeletal sensitivity is increased.I型骨质疏松症患者血清完整甲状旁腺激素浓度与骨重塑的关系:骨骼敏感性增加的证据
Osteoporos Int. 1990 Oct;1(1):14-22. doi: 10.1007/BF01880411.
6
Regulation of circulating parathyroid hormone levels: normal physiology and consequences in disorders of mineral metabolism.循环甲状旁腺激素水平的调节:矿物质代谢紊乱中的正常生理及影响
Klin Wochenschr. 1975 Oct 15;53(20):939-54. doi: 10.1007/BF01614437.
7
Parathyroid hormone secretion and 25-hydroxyvitamin D levels in primary osteoporosis.原发性骨质疏松症中甲状旁腺激素分泌及25-羟基维生素D水平
Calcif Tissue Res. 1977 May;22 Suppl:495-6. doi: 10.1007/BF02064141.
8
Bone cells and remodelling surfaces in acromegaly.肢端肥大症中的骨细胞与重塑表面
Calcif Tissue Res. 1977 May;22 Suppl:255-9. doi: 10.1007/BF02064075.
9
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.正常受试者和骨质疏松患者的肠道钙吸收及血清维生素D代谢产物:年龄和膳食钙的影响
J Clin Invest. 1979 Sep;64(3):729-36. doi: 10.1172/JCI109516.
J Lab Clin Med. 1967 May;69(5):810-8.
4
Relationship between serum phosphate concentration and bone resorption in osteoporosis.骨质疏松症中血清磷酸盐浓度与骨吸收的关系。
J Lab Clin Med. 1967 Jan;69(1):110-5.
5
Human parathyroid hormone: glandular and secreted molecular species.人甲状旁腺激素:腺源性及分泌的分子种类。
Am J Med. 1971 May;50(5):630-8. doi: 10.1016/0002-9343(71)90118-5.
6
Clinical significance and pathogenesis of osteoporosis.骨质疏松症的临床意义及发病机制。
Br Med J. 1971 Mar 13;1(5749):571-6. doi: 10.1136/bmj.1.5749.571.
7
Radioimmunoassay of human parathyroid hormone in serum.血清中人类甲状旁腺激素的放射免疫测定
J Clin Invest. 1971 Jan;50(1):21-34. doi: 10.1172/JCI106476.
8
Parathyroid hormone: secretion and metabolism in vivo.甲状旁腺激素:体内的分泌与代谢
Proc Natl Acad Sci U S A. 1971 Dec;68(12):2986-91. doi: 10.1073/pnas.68.12.2986.
9
Native human parathyroid hormone: an immunochemical investigation.天然人甲状旁腺激素:一项免疫化学研究。
Proc Natl Acad Sci U S A. 1970 Sep;67(1):415-22. doi: 10.1073/pnas.67.1.415.
10
Fractionation of circulating parathyroid hormone (PTH) in man.人体循环甲状旁腺激素(PTH)的分级分离
J Lab Clin Med. 1971 Nov;78(5):814.